Cinven completes acquisition of Amdipharm
European private equity firm Cinven has completed its acquisition of Amdipharm, the family-owned international niche pharmaceuticals business, for a total consideration of GBP367m. This deal follows Cinven’s acquisition of Mercury Pharma, an international specialty pharmaceuticals company, in August 2012. Amdipharm will be merged, over time, with Mercury Pharma. The